TEVA TEVA HEALTH SYSTEMS Trademark

Trademark Overview

On Thursday, April 10, 2008, a trademark application was filed for TEVA TEVA HEALTH SYSTEMS with the United States Patent and Trademark Office. The USPTO has given the TEVA TEVA HEALTH SYSTEMS trademark a serial number of 77445200. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 12, 2016. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The TEVA TEVA HEALTH SYSTEMS trademark is filed in the Pharmaceutical Products category with the following description:

A house mark for a full line of allergy, analgesic, anti-bacterial, antibiotic, anti-convulsant, anti-depressant, anti-emetic, anti-fungal, anti-hypertensive, anti-infective, anti-inflammatory, anti-neoplastic, anti-olytic, anti-viral, cardiovascular, central nervous system, contraceptive, corticosteroid, dermatologic, diabetes, diuretic, non-steroidal anti-inflammatory, oncolytic, prokinetic and respiratory pharmaceuticals
teva teva health systems

General Information

Serial Number77445200
Word MarkTEVA TEVA HEALTH SYSTEMS
Filing DateThursday, April 10, 2008
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 12, 2016
Registration Number3733174
Registration DateTuesday, January 5, 2010
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 20, 2009

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"HEALTH SYSTEMS"
Description of MarkThe mark consists of the words "TEVA" and "TEVA HEALTH SYSTEMS" in stylized form.
Goods and ServicesA house mark for a full line of allergy, analgesic, anti-bacterial, antibiotic, anti-convulsant, anti-depressant, anti-emetic, anti-fungal, anti-hypertensive, anti-infective, anti-inflammatory, anti-neoplastic, anti-olytic, anti-viral, cardiovascular, central nervous system, contraceptive, corticosteroid, dermatologic, diabetes, diuretic, non-steroidal anti-inflammatory, oncolytic, prokinetic and respiratory pharmaceuticals
Translation of Words in MarkThe foreign wording in the mark translates into English as nature.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 12, 2016
Primary Code005
First Use Anywhere DateTuesday, October 10, 2006
First Use In Commerce DateTuesday, October 10, 2006

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Friday, August 12, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, January 5, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, October 20, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 20, 2009PUBLISHED FOR OPPOSITION
Monday, September 14, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 8, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 8, 2009EXAMINER'S AMENDMENT ENTERED
Tuesday, September 8, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 8, 2009EXAMINERS AMENDMENT E-MAILED
Tuesday, September 8, 2009EXAMINERS AMENDMENT -WRITTEN
Sunday, June 14, 2009NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, June 14, 2009FINAL REFUSAL E-MAILED
Sunday, June 14, 2009FINAL REFUSAL WRITTEN
Tuesday, May 5, 2009AMENDMENT FROM APPLICANT ENTERED
Tuesday, May 5, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 4, 2009PAPER RECEIVED
Tuesday, March 10, 2009NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, March 10, 2009PRIORITY ACTION E-MAILED
Tuesday, March 10, 2009PRIORITY ACTION WRITTEN
Thursday, January 15, 2009PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, December 29, 2008WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, December 18, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, December 16, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 16, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 16, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 11, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 11, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 5, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 5, 2008NON-FINAL ACTION E-MAILED
Wednesday, November 5, 2008NON-FINAL ACTION WRITTEN
Tuesday, November 4, 2008PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, September 15, 2008WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, September 2, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 28, 2008ASSIGNED TO LIE
Wednesday, August 20, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 29, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 29, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 29, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 29, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 17, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 17, 2008NON-FINAL ACTION E-MAILED
Saturday, May 17, 2008NON-FINAL ACTION WRITTEN
Tuesday, May 13, 2008ASSIGNED TO EXAMINER
Monday, April 14, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

teva systems health anti inflammatory corticosteroid contraceptive system nervous cardiovascular central dermatologic diabetes